This article was originally published in The Gray Sheet
Regulatory Affairs Professional Society draft code of ethics could address Sec. 802(f) of the FDA Export Reform & Enhancement Act, governing export of certain unapproved products, Hogan & Hartson attorney Linda Horton opines at RAPS Asia Global Awareness conference in Universal City, Calif. June 24. Although a RAPS code is still under development, the former FDAer described Sec. 802(f) as a potential quandary for ethicists, since I don't think FDA has ever invoked" the provision...
You may also be interested in...
The Regulatory Affairs Professionals Society will circulate a draft version of its evolving ethics code for member comment by the end of July
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.